218150 — Milae Bioresources Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩96bn
- KR₩77bn
- KR₩60bn
- 63
- 23
- 22
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 13,671 | 11,786 | 26,997 | 26,678 | 24,540 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,613 | 8,766 | 8,569 | 9,295 | 7,932 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 26,639 | 25,313 | 41,524 | 41,972 | 37,935 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11,086 | 11,263 | 11,436 | 11,387 | 11,191 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 38,519 | 39,064 | 55,390 | 56,095 | 51,591 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8,586 | 8,224 | 7,432 | 14,941 | 7,126 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 8,858 | 8,615 | 22,505 | 15,350 | 7,438 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 29,661 | 30,449 | 32,885 | 40,745 | 44,153 |
Total Liabilities & Shareholders' Equity | 38,519 | 39,064 | 55,390 | 56,095 | 51,591 |
Total Common Shares Outstanding |